A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

  First | 1 2 3        [Sort by number of followers]   [Restore default list]

  Subjects -> PHARMACY AND PHARMACOLOGY (Total: 575 journals)
Showing 401 - 253 of 253 Journals sorted alphabetically
Microbial Drug Resistance     Hybrid Journal   (Followers: 3)
Molecular Informatics     Hybrid Journal   (Followers: 5)
Molecular Pharmacology     Hybrid Journal   (Followers: 2)
Molekul     Open Access   (Followers: 3)
Natural Product Communications     Open Access  
Nature Reviews Drug Discovery     Full-text available via subscription   (Followers: 320)
Naunyn-Schmiedeberg's Archives of Pharmacology     Hybrid Journal  
NeuroMolecular Medicine     Hybrid Journal  
Neuropharmacology     Hybrid Journal   (Followers: 5)
Neuropsychopharmacology     Hybrid Journal   (Followers: 17)
Neuropsychopharmacology Reports     Open Access  
Nigerian Journal of Natural Products and Medicine     Full-text available via subscription  
OA Drug Design & Delivery     Open Access  
OA Medical Hypothesis     Open Access  
Obesity Facts     Open Access   (Followers: 8)
Open Pharmacoeconomics & Health Economics Journal     Open Access   (Followers: 1)
Open Pharmacology Journal     Open Access  
OpenNano     Open Access   (Followers: 1)
Orbital - The Electronic Journal of Chemistry     Open Access   (Followers: 1)
Oriental Pharmacy and Experimental Medicine     Partially Free   (Followers: 2)
Pain and Therapy     Open Access   (Followers: 3)
Particulate Science and Technology: An International Journal     Hybrid Journal   (Followers: 1)
PDA Journal of Pharmaceutical Science and Technology     Full-text available via subscription   (Followers: 34)
Pediatric Drugs     Full-text available via subscription   (Followers: 3)
Pediatric Pharmacology     Open Access   (Followers: 1)
Pharmaceutica Analytica Acta     Open Access  
Pharmaceutical Biology     Open Access  
Pharmaceutical Care-La Farmacoterapia     Open Access  
Pharmaceutical Chemistry Journal     Hybrid Journal  
Pharmaceutical Development and Technology     Hybrid Journal   (Followers: 19)
Pharmaceutical Executive     Full-text available via subscription   (Followers: 2)
Pharmaceutical Fronts     Open Access   (Followers: 10)
Pharmaceutical Historian     Open Access  
Pharmaceutical Journal     Free   (Followers: 8)
Pharmaceutical Journal of Sri Lanka     Open Access  
Pharmaceutical Medicine     Full-text available via subscription   (Followers: 4)
Pharmaceutical Nanotechnology     Hybrid Journal  
Pharmaceutical Patent Analyst     Full-text available via subscription   (Followers: 3)
Pharmaceutical Research     Hybrid Journal   (Followers: 93)
Pharmaceutical Statistics     Hybrid Journal   (Followers: 15)
Pharmaceutical Technology     Full-text available via subscription   (Followers: 7)
Pharmaceuticals     Open Access   (Followers: 4)
Pharmacia     Open Access  
Pharmaciana     Open Access  
PharmacoEconomics     Full-text available via subscription   (Followers: 26)
PharmacoEconomics & Outcomes News     Full-text available via subscription   (Followers: 3)
PharmacoEconomics German Research Articles     Full-text available via subscription  
PharmacoEconomics Spanish Research Articles     Hybrid Journal   (Followers: 1)
Pharmacoepidemiology and Drug Safety     Hybrid Journal   (Followers: 33)
Pharmacogenetics and Genomics     Hybrid Journal   (Followers: 1)
Pharmacogenomics     Hybrid Journal   (Followers: 7)
Pharmacogenomics and Personalized Medicine     Open Access   (Followers: 2)
Pharmacogenomics Journal     Hybrid Journal   (Followers: 5)
Pharmacognosy Communications     Partially Free  
Pharmacognosy Magazine     Open Access   (Followers: 2)
Pharmacognosy Research     Open Access   (Followers: 2)
Pharmacological Reports     Hybrid Journal  
Pharmacological Research     Hybrid Journal   (Followers: 1)
Pharmacological Research - Modern Chinese Medicine     Open Access  
Pharmacological Reviews     Hybrid Journal   (Followers: 2)
Pharmacology     Full-text available via subscription  
Pharmacology & Therapeutics     Hybrid Journal   (Followers: 3)
Pharmacology & Pharmacy     Open Access   (Followers: 1)
Pharmacology Biochemistry and Behavior     Hybrid Journal   (Followers: 2)
Pharmacology Research & Perspectives     Open Access  
Pharmacon : Jurnal Farmasi Indonesia     Open Access  
Pharmacopsychiatry     Hybrid Journal   (Followers: 3)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy     Hybrid Journal   (Followers: 39)
Pharmactuel     Open Access   (Followers: 1)
Pharmacy     Open Access   (Followers: 4)
Pharmacy & Pharmacology     Open Access   (Followers: 1)
Pharmacy Education     Full-text available via subscription   (Followers: 11)
Pharmacy Practice (Internet)     Open Access   (Followers: 8)
Pharmakon : Arzneimittel in Wissenschaft und Praxis     Full-text available via subscription   (Followers: 1)
PharmaNutrition     Hybrid Journal   (Followers: 3)
PharmaTutor     Open Access  
Pharmazeutische Industrie     Full-text available via subscription   (Followers: 9)
Pharmazeutische Zeitung     Full-text available via subscription   (Followers: 11)
Pharmazie in Unserer Zeit (Pharmuz)     Hybrid Journal   (Followers: 10)
Physiology International     Full-text available via subscription   (Followers: 3)
Plant Products Research Journal     Full-text available via subscription  
Planta Medica     Hybrid Journal   (Followers: 4)
Planta Medica International Open     Open Access  
Prescriber     Hybrid Journal   (Followers: 9)
Progress in Neuro-Psychopharmacology and Biological Psychiatry     Hybrid Journal   (Followers: 8)
Psychiatry and Clinical Psychopharmacology     Open Access   (Followers: 1)
Psychopharmacology     Hybrid Journal   (Followers: 15)
Pulmonary Pharmacology & Therapeutics     Hybrid Journal   (Followers: 2)
PZ Prisma : Materialien zur Fort- und Weiterbildung     Full-text available via subscription  
Redox Report     Open Access  
Regulatory Mechanisms in Biosystems     Open Access   (Followers: 1)
Regulatory Toxicology and Pharmacology     Hybrid Journal   (Followers: 41)
Research & Reviews : A Journal of Drug Design & Discovery     Full-text available via subscription  
Research & Reviews : A Journal of Pharmaceutical Science     Full-text available via subscription  
Research & Reviews : A Journal of Pharmacognosy     Full-text available via subscription  
Research & Reviews : A Journal of Pharmacology     Full-text available via subscription   (Followers: 1)
Research in Pharmaceutical Sciences     Open Access   (Followers: 3)
Research in Social and Administrative Pharmacy     Hybrid Journal   (Followers: 3)
Research Journal of Pharmacognosy     Open Access  
Research Results in Pharmacology     Open Access  
Reviews of Physiology, Biochemistry and Pharmacology     Hybrid Journal   (Followers: 4)
Reviews on Clinical Pharmacology and Drug Therapy     Full-text available via subscription  
Revista Colombiana de Ciencias Químico-Farmacéuticas     Open Access  
Revista Cubana de Plantas Medicinales     Open Access   (Followers: 1)
Revista de Ciências Farmacêuticas Básica e Aplicada     Open Access  
Revista Mexicana de Ciencias Farmaceuticas     Open Access  
Revue de Médecine et de Pharmacie     Full-text available via subscription  
Safety and Risk of Pharmacotherapy     Open Access   (Followers: 1)
Saudi Pharmaceutical Journal     Open Access  
Scandinavian Journal of Clinical and Laboratory Investigation     Hybrid Journal   (Followers: 7)
Scientia Pharmaceutica     Open Access  
Seminars in Hematology     Hybrid Journal   (Followers: 12)
Seminars in Oncology Nursing     Full-text available via subscription   (Followers: 10)
Separation Science plus (SSC plus)     Hybrid Journal  
Side Effects of Drugs Annual     Full-text available via subscription   (Followers: 2)
Skin Pharmacology and Physiology     Full-text available via subscription   (Followers: 6)
Substance Abuse : Research and Treatment     Open Access   (Followers: 5)
Suchttherapie     Hybrid Journal   (Followers: 1)
Sustainable Chemistry and Pharmacy     Full-text available via subscription   (Followers: 1)
Synfacts     Hybrid Journal   (Followers: 5)
SynOpen     Open Access  
The Botulinum J.     Hybrid Journal  
The Brown University Psychopharmacology Update     Hybrid Journal   (Followers: 2)
The Medical Letter     Full-text available via subscription   (Followers: 18)
The Pink Sheet     Full-text available via subscription   (Followers: 14)
The Pink Sheet Daily     Full-text available via subscription   (Followers: 4)
Therapeutic Advances in Drug Safety     Open Access   (Followers: 3)
Therapeutic Advances in Psychopharmacology     Open Access   (Followers: 4)
Therapeutic Advances in Vaccines     Hybrid Journal   (Followers: 1)
Therapeutic Drug Monitoring     Hybrid Journal   (Followers: 3)
Therapeutic Innovation & Regulatory Science     Hybrid Journal   (Followers: 7)
Thérapie     Full-text available via subscription   (Followers: 1)
TheScientist     Free   (Followers: 5)
Toxicological & Environmental Chemistry     Hybrid Journal   (Followers: 2)
Toxicological Research     Hybrid Journal  
Toxicological Sciences     Hybrid Journal   (Followers: 11)
Toxicology     Hybrid Journal   (Followers: 18)
Toxicology and Applied Pharmacology     Hybrid Journal   (Followers: 24)
Toxicology and Industrial Health     Hybrid Journal   (Followers: 6)
Toxicology in Vitro     Hybrid Journal   (Followers: 11)
Toxicology International     Full-text available via subscription   (Followers: 5)
Toxicology Letters     Hybrid Journal   (Followers: 15)
Toxicology Mechanisms and Methods     Hybrid Journal   (Followers: 7)
Toxicology Research     Partially Free   (Followers: 8)
Toxicon     Hybrid Journal   (Followers: 5)
Toxicon : X     Open Access  
Toxin Reviews     Hybrid Journal  
Translational Psychiatry     Open Access   (Followers: 15)
Trends in Peptide and Protein Sciences     Open Access  
Trends in Pharmacological Sciences     Full-text available via subscription   (Followers: 19)
Tropical Journal of Pharmaceutical Research     Open Access  
Ukrainian Biopharmaceutical Journal     Open Access  
Vascular Pharmacology     Hybrid Journal   (Followers: 2)
World Mycotoxin Journal     Hybrid Journal   (Followers: 3)
Yakugaku Zasshi     Open Access   (Followers: 1)
Zeitschrift für Phytotherapie     Hybrid Journal   (Followers: 1)
Актуальні питання фармацевтичної та медичної науки та практики     Open Access  
Фармацевтичний часопис     Open Access  

  First | 1 2 3        [Sort by number of followers]   [Restore default list]

Similar Journals
Journal Cover
American Journal of Therapeutics
Journal Prestige (SJR): 0.399
Citation Impact (citeScore): 1
Number of Followers: 13  
 
  Hybrid Journal Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1075-2765 - ISSN (Online) 1536-3686
Published by LWW Wolters Kluwer Homepage  [297 journals]
  • Activated Clotting Times Demonstrate Weak Correlation With Heparin Dosing
           in Adult Extracorporeal Membrane Oxygenation

    • Free pre-print version: Loading...

      Authors: Hohlfelder; Benjamin; Kelly, Daniel; Hoang, Minh; Anger, Kevin E.; Sylvester, Katelyn W.; Kaufman, Richard M.; Connors, Jean M.
      Abstract: imageBackground: The optimal monitoring strategy for anticoagulation management in extracorporeal membrane oxygenation (ECMO) remains a clinical controversy. The Extracorporeal Life Support Organization Anticoagulation Guidelines suggest that multiple anticoagulation assays may be needed but do not specify a preferred management strategy.Study Question: In adult ECMO patients, which anticoagulation assays demonstrate the highest correlation with unfractionated heparin (UFH) dose requirements?Study Design: We performed a retrospective chart review of adult patients cannulated to ECMO between February 2013 and July 2015.Measures and Outcomes: The primary outcome was the correlation between activated clotting time (ACT), activated partial thromboplastin time (aPTT), and anti-Xa and UFH dose. Secondary outcomes included correlations between anticoagulation assays. Correlations were calculated for the entire cohort, with subgroup analysis of venoarterial and venovenous ECMO patients.Results: Forty-eight patients were included in the analysis, 26 initially cannulated to venoarterial ECMO and 22 to veno-venous ECMO. The median duration of ECMO therapy was 7 days. Mean UFH requirements were 1149 units/h or 15.3 units/kg/h. Total UFH dose was most correlated with anti-Xa levels (r = 0.467), whereas weight-based heparin dose was most correlated with aPTT (0.405). For correlations between anticoagulation assays, anti-Xa and aPTT were more highly correlated with each other (r = 0.633) compared with ACT.Conclusions: In adult patients requiring ECMO, anti-Xa and aPTT monitoring were correlated more closely with UFH dosing than ACT.
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Prehospital Care of Coronary Artery Disease and Its Major Risk Factors in
           Geropsychiatric Inpatients

    • Free pre-print version: Loading...

      Authors: Manu; Peter; Grudnikoff, Eugene; Constantin, Dan A.; Rogozea, Liliana M.; Rucsanda, Ioana; Leaşu, Florin; Dinu, Eleonora
      Abstract: imageBackground: Older adults with serious mental illness have a high prevalence of coronary artery disease and of its major risk factors, that is, arterial hypertension, dyslipidemia, and diabetes mellitus. The prevalence and clinical control of these conditions have not been compared in geropsychiatric inpatients with dementia versus those with mood or psychotic disorders.Study Question: What is the prevalence and acuity of coronary artery disease, arterial hypertension, dyslipidemia, and diabetes mellitus among patients with dementia, mood, and psychotic disorders admitted for geropsychiatric care?Study Design: Patients 65 years of age or older were identified in a cohort of 1000 patients consecutively admitted over a 3-year period to the geropsychiatric unit of a 200-bed mental health hospital in suburban New York. All patients had a structured clinical and laboratory evaluation within 72 hours of admission.Data Sources: Primary psychiatric diagnoses, medical history, the frequency of poorly controlled cardiometabolic comorbidity requiring an immediate change in the management plan, and the Charlson Comorbidity Index (CCI).Results: The 65 years and older patient sample (N = 689) had a mean age of 74.8 years, and 58.8% of the subjects were women. The 205 patients with dementia were older (P < 0.001) than the 337 patients with mood disorders and the 147 patients with psychotic syndromes. The numbers of medical conditions and the CCI after exclusion of dementia were similar in patients with dementia versus patients without dementia. A substantial number of patients had poorly controlled arterial hypertension (51.2%), dyslipidemia (25.4%), diabetes (24.2%), and coronary artery disease (15.4%). Patients with dementia had a lower prevalence of poorly controlled dyslipidemia (P = 0.0006), diabetes (P = 0.0089), and coronary artery disease (P = 0.045).Conclusions: Compared with mood or psychotic disorder, a diagnosis of dementia with behavioral disturbance seemed to be associated with better control of coronary artery disease, dyslipidemia, and diabetes mellitus in geropsychiatric inpatients.
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • The Attitudes and Beliefs of Family Physicians Regarding the Use of
           Medical Cannabis, Knowledge of Side Effects, and Barriers to Use: A
           Comparison Between Residents and Specialists

    • Free pre-print version: Loading...

      Authors: Abo Ziad; Ramzi; Grynbaum, Mirta Beatriz; Peleg, Roni; Treister-Goltzman, Yulia
      Abstract: imageBackground: Israel has a regulated system with clearly defined indications for treatment with medical cannabis.Study Question: The main question was whether family physicians in southern Israel face barriers/knowledge gaps in prescribing cannabis for medical indications. The secondary question was whether there was a difference between residents and specialists in family medicine.Study Design: A questionnaire-based cross-sectional study.Measures and Outcomes: Attitudes of the participating physicians on the use of medical cannabis; comparison of attitudes of specialists in family medicine and residents on the use of medical cannabis.Results: One hundred and fifty-two family physicians participated in the study including 48 residents. More than 78% supported the use of medical cannabis and about 63% supported it's legalization. About 84% of the physicians believed that medical cannabis helped cancer patients and 82% believed it helped in the chronic pain. Only 28.3% believed that family physicians should recommend the use of medical cannabis. The physicians were well aware of the psychiatric (82%) and the neurological (78%) adverse effects of medical cannabis. Most (68%) were not willing to prescribe medical cannabis. No socio-demographic characteristic was associated with willingness to prescribe cannabis. About 95% of the physicians believed that the main barrier to recommending treatment was its potential for abuse, 66% percent—the danger that it would leak to the general public. About 60% of the specialists were not prepared to undergoing training in the prescription of medical cannabis compared with 31% of the residents (P = 0.004).Conclusions: Family physicians are concerned about recommending medical cannabis. It is encouraging that residents are motivated to undergo training to prescribe medical cannabis. There remain medical indications and adverse effects that family physicians are less aware of. Further studies should focus on effective ways to improve the level of physicians' knowledge on the issue.
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Pharmacological Management of Obesity: A Century of Expert Opinions in
           Cecil Textbook of Medicine

    • Free pre-print version: Loading...

      Authors: Manu; Peter; Lăcătuşu, Cristina-Mihaela; Rogozea, Liliana M.; Cernea, Simona
      Abstract: imageBackground: Innovations in drug therapy for obesity have had a limited impact on the body mass index, prevalence of medical complications, quality of life, and work potential of a substantial majority of affected persons.Study Question: What are the milestones of the changes in the expert approach to the pharmacological management of obesity in the past century?Study Design: To determine the changes in the experts' approach to the management of obesity, as presented in a widely used textbook in the United States.Data Sources: The primary sources were chapters describing the management of obesity in the 26 editions of Cecil Textbook of Medicine published from 1927 through 2020. Secondary sources were publications retrieved from Medline that clarified technical issues related to the development, regulatory approval, and use of the drugs mentioned in the Cecil Textbook of Medicine.Results: Pharmacological interventions aimed at increasing caloric expenditures through thermogenesis were recommended from 1927 through 1943. Thyroid extracts were prescribed even in the absence of demonstrated hypothyroidism or decreased basal metabolic rate throughout this period. Dinitrophenol was mentioned in 1937, but was banned soon thereafter. Appetite suppression with amphetamine was considered useful from 1943 through 1988, after which the drug was replaced with other centrally acting molecules, such as fenfluramine in 1988, sibutramine in 2000, and rimonabant in 2008, which were in turn withdrawn because of major adverse effects. In the past decade, obesity has been treated with the appetite suppressants phentermine-topiramate, bupropion-naltrexone, lorcaserin, and liraglutide, and with orlistat, a drug promoting fat malabsorption. The change in weight produced by these drugs is generally modest and transient.Conclusions: The pharmacological management of obesity has remained frustratingly inefficient. The reasons for the relative lack of success may reside in the ever-growing access to dense, palatable, and relatively inexpensive food, coupled with the decrease in energy expenditure created by a sedentary lifestyle.
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Use of Anticoagulants in COVID-19: A Review

    • Free pre-print version: Loading...

      Authors: Ngu; Sam; Smith, John Kolton; Goldin, Mark
      Abstract: imageBackground: Coronavirus disease 2019 (COVID-19) is associated with elevated rates of major and fatal thrombotic events, postulated to be the result of a hypercoagulable state mediated through inflammatory and immunomodulatory mechanisms. Early observational studies showed that disease severity and elevated serum D-dimer levels can predict thrombotic risk in patients hospitalized with COVID-19 and reported an alarming phenomenon of breakthrough thrombosis despite standard-of-care prophylaxis, suggesting the need for enhanced thromboprophylactic strategies.Areas of Uncertainty: Data on anticoagulant agent selection, dosing, and duration for COVID-19 inpatients are now poised to inform updated professional society guidance. However, there remains limited high-quality data regarding postdischarge and especially ambulatory patients with COVID-19.Data Sources: This review includes published, peer-reviewed, observational, and randomized controlled trial data and major professional society guidance informing thrombosis prevention and treatment in patients with COVID-19.Therapeutic Advances: There remains great variability in the approach to anticoagulation in COVID-19. This article will review pathogenesis of COVID-related thrombosis and the evidence guiding thromboprophylaxis particularly in inpatients, with attention to the INSPIRATION, ACTION, RAPID, HEP-COVID, and multiplatform trials. Emerging thromboprophylaxis data from the postdischarge setting (particularly the recently published MICHELLE trial), and the outpatient setting, will be examined. Finally, thrombosis treatment considerations will briefly be reviewed.Conclusions: Substantial high-quality data support practice changes to COVID-19 thromboprophylaxis. Risk stratification by setting, disease severity, and biomarkers such as D-dimer is critical in considering choice, dose, and duration of anticoagulants.
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Potential Association of Doxycycline With the Onset of Primary Sclerosing
           Cholangitis: A Case Series

    • Free pre-print version: Loading...

      Authors: Buness; James Gage; Ali, Ahmad Hassan; Tabibian, James H.; Buness, Cynthia W.; Cox, Kenneth L.; Lindor, Keith D.
      Abstract: imageBackground: Primary sclerosing cholangitis (PSC) is linked to inflammatory bowel diseases (IBD). Evidence suggests an association between the gut microbiome and PSC. However, the putative relationship between exposure to antibiotics and onset of PSC has never been reported. We observed 3 cases in which patients without antecedent liver or bowel issues developed symptoms leading to diagnosis of IBD and subsequently PSC after being exposed to doxycycline. We aimed to identify, through the PSC Partners national patient registry, additional cases of PSC in which there is a temporal relationship between exposure to doxycycline and onset of PSC or PSC-IBD.Areas of Uncertainty: The etiopathogenesis of PSC remains an enigma.Data Sources: We collected data from patients with PSC and PSC-IBD in which there seemed to be a temporal relationship between exposure to doxycycline and PSC. Time from doxycycline exposure to: (1) onset of PSC or PSC-IBD symptoms and (2) diagnosis of PSC were documented for each patient. Descriptive statistical analyses were performed.Results: We identified 6 additional patients with PSC or PSC-IBD in whom there was a temporal relationship between exposure to doxycycline and onset of PSC or PSC-IBD. The median age of these 9 patients was 20 years, 6 were female, and 7 had ulcerative colitis. The median time from doxycycline exposure to onset of first symptoms was 3 months, and median time from doxycycline exposure to diagnosis of PSC was 15 months.Therapeutic Hypothesis: We describe 9 cases of PSC and PSC-IBD in which there seem to be a temporal relationship between exposure to doxycycline and onset of PSC.
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Remdesivir-Associated Pancreatitis

    • Free pre-print version: Loading...

      Authors: Khadka; Sushmita; Williams, Karen; Solanki, Shantanu
      Abstract: imageWe report a case of acute pancreatitis that developed after four days of remdesivir therapy in a patient being treated for COVID-19. Despite improvement in patient's respiratory status, abdominal pain worsened and clinical signs and symptoms progressed to a diagnosis of acute pancreatitis 4 days after initiation of remdesivir therapy. Withdrawal of remdesivir paired with medical management of acute pancreatitis led to the resolution of pancreatitis within three days. To our knowledge, this is the first case report depicting remdesivir as a possible cause of acute pancreatitis.
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Drug Therapy for Unexplained Dyspnea in Post–COVID-19 Fatigue Syndrome:
           Empagliflozin and Sildenafil

    • Free pre-print version: Loading...

      Authors: Manu; Peter
      Abstract: No abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Lamivudine-Associated Lactic Acidosis

    • Free pre-print version: Loading...

      Authors: Konala; Venu Madhav; Adapa, Sreedhar; Dinesh, Kumar P.; Agrawal, Nikhil; Naramala, Srikanth; Dhingra, Hemant; Aronow, Wilbert S.
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Takotsubo Cardiomyopathy Secondary to Rituximab

    • Free pre-print version: Loading...

      Authors: Gupta; Rahul; Sen, Aditi; Khosla, Jagjit; Ranchal, Purva; Aronow, Wilbert S.; Shehu, Merita
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Re: Expression of Concern for Bryant A, Lawrie TA, Dowswell T, Fordham EJ,
           Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of
           COVID-19 Infection. Am J Ther. 2022;29:e232.

    • Free pre-print version: Loading...

      Authors: Bryant; Andrew; Lawrie, Theresa A.; Fordham, Edmund J.; Mitchell, Scott
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Angiotensin II Receptor Blocking Drugs May Increase Severity of
           Coronavirus Disease 2019 Infection

    • Free pre-print version: Loading...

      Authors: Cobos-Campos; Raquel; Bermúdez-Ampudia, Cristina; Orruño, Estibaliz; Apiñaniz, Antxon; García, Sainza; Cordero, Jose; Argaluza, Julene; Sáez de Lafuente, Arantza; Parraza, Naiara
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • A Case of Severe Colitis in an HIV-Positive Patient With CD4
           Count>200cells/μL

    • Free pre-print version: Loading...

      Authors: Afsana; Hrede; Geevarghese, John; Salwan, Anu; Gross, Craig; Smith, Miriam A.
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Interaction Between Levodopa and Banana in a Patient With Parkinson's
           Disease

    • Free pre-print version: Loading...

      Authors: Hotozuka; Satomi; Yasu, Takeo; Hikita, Eri; Shirota, Mikio
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Effect of Wrist–Ankle Acupuncture on Propofol Dosage in Painless
           Gastroscopy of Elderly Patients: A Randomized Controlled Trial

    • Free pre-print version: Loading...

      Authors: Dong; Yajing; Liang, Zhi; Xu, Zhe; Hao, Wei; Wang, Dandan; Yang, Jing; Yuan, Jun
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Intranasal Cellulose Powder For Pregnant Women With Allergic Rhinitis

    • Free pre-print version: Loading...

      Authors: Qiao; Xiao-Feng; Zhang, Jian; Zhang, Qiang-Wei; Li, Xin; Bai, Yin-Huan; Li, Tong-Li; Zhang, Huan-Ping
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Tocilizumab-Associated Cecal Perforation in COVID-19 Pneumonia

    • Free pre-print version: Loading...

      Authors: Adunse; Josephine; Kesireddy, Nithin; Khokher, Waleed; Mudiyanselage, Prabath Herath; Ali, Hyder; Assaly, Ragheb
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Amikacin Monotherapy for Peripherally Inserted Central Catheter-Related
           Bloodstream Infection due to Tsukamurella pulmonis

    • Free pre-print version: Loading...

      Authors: Beran; Azizullah; Mhanna, Mohammed; Srour, Omar; Hochanadel, Alicia; Luttmann, Kelly; Georgescu, Claudiu; Assaly, Ragheb
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Transient Psychosis After Low-Dose Pregabalin Discontinuation

    • Free pre-print version: Loading...

      Authors: Uçar; Hüseyin; Gundogmus, İbrahim; Bolu, Abdullah; Çelik, Cemil
      Abstract: No abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Stool Osmotic Gap: An Alternative to Invasive Workup of Chronic Diarrhea
           Secondary to Glucagon-Like Peptide-1 Agonist Use

    • Free pre-print version: Loading...

      Authors: Sheehan; Erin; Sample, Jack; Kassabo, Waleed; Madkhli, Mohammed; Assaly, Ragheb
      Abstract: No abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Alcoholic Ketoacidosis: Review of Current Practice and Association of
           Treatments to Improvement

    • Free pre-print version: Loading...

      Authors: Sidlak; Alexander M.; Trautman, William J.; Lynch, Michael J.; Marino, Ryan T.
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Sertraline-Associated Immunoglobulin A Vasculitis

    • Free pre-print version: Loading...

      Authors: Fatima; Rawish; Acharya, Ashu; Bozorgnia, Farshid; Garg, Anu; Altorok, Nazem
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Successful Ziprasidone Treatment for Resistant
           Attention-Deficit/Hyperactivity Disorder and Provisional Motor Tic
           Disorder

    • Free pre-print version: Loading...

      Authors: Naguy; Ahmed; Allami, Shaimaa; Abuzeid, Mohamed Y.; Alamiri, Bibi
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Typical versus Atypical Antipsychotics for Acute Mania:
           Psychopharmacological Considerations

    • Free pre-print version: Loading...

      Authors: Naguy; Ahmed
      Abstract: imageNo abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Haloperidol Toxicity and Lipid Emulsion Treatment

    • Free pre-print version: Loading...

      Authors: Sohn; Ju-Tae
      Abstract: No abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Malignant Hyperthermia and Cisatracurium During Severe SARS-CoV-2
           Infection

    • Free pre-print version: Loading...

      Authors: Sohn; Ju-Tae
      Abstract: No abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Brexpiprazole in the Treatment of Cannabis Withdrawal Psychotic Disorder

    • Free pre-print version: Loading...

      Authors: Kung; Fan-Hsuan; Lin, Hung-Yi; Tai, Yueh-Ming; Chang, Hsin-An; Chiao, Hai-Yu; Huang, Yu-Chieh; Tzeng, Nian-Sheng
      Abstract: No abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
  • Kava Kava Induced Acute Liver Failure

    • Free pre-print version: Loading...

      Authors: Raziq; Fazal I.
      Abstract: No abstract available
      PubDate: Fri, 01 Jul 2022 00:00:00 GMT-
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.229.124.74
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-